Literature DB >> 10526578

Interleukin-12, a key cytokine in Th1-mediated autoimmune diseases.

L Adorini1.   

Abstract

Interleukin 12 (IL-12) is a heterodimeric cytokine produced primarily by antigen-presenting cells (APCs) which plays a key role in promoting type 1 T helper cell (Th1) responses. The powerful activity of IL-12 requires tight control, which is exerted at various levels. Primary control is exerted on IL-12 production by APCs, a major factor driving the response towards the Th1 or Th2 phenotype. Another level of control regulates expression of the IL-12 receptor (IL-12R), which is composed of two subunits, beta 1 and beta 2. The IL-12R beta 2 subunit has signal-transducing capacity and modulation of its expression is central to the regulation of IL-12 responsiveness. Endogenous IL-12 plays an important role in host defense against infection by a variety of intracellular pathogens. Its Th1-promoting activity, however, also favors Th1-mediated immunopathology and, in particular, the induction of Th1-mediated autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10526578     DOI: 10.1007/s000180050400

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  16 in total

1.  Inhibition of interleukin-12 production by auranofin, an anti-rheumatic gold compound, deviates CD4(+) T cells from the Th1 to the Th2 pathway.

Authors:  T S Kim; B Y Kang; M H Lee; Y K Choe; S Y Hwang
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

2.  Immune complex-stimulated production of interleukin-12 in peripheral blood mononuclear cells is regulated by the complement system.

Authors:  A Tejde; L Mathsson; K N Ekdahl; B Nilsson; J Rönnelid
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

3.  Protein microarray analysis of disease activity in pediatric inflammatory bowel disease demonstrates elevated serum PLGF, IL-7, TGF-beta1, and IL-12p40 levels in Crohn's disease and ulcerative colitis patients in remission versus active disease.

Authors:  Howard A Kader; Velizar T Tchernev; Ebenezer Satyaraj; Serguei Lejnine; Gregory Kotler; Stephen F Kingsmore; Dhavalkumar D Patel
Journal:  Am J Gastroenterol       Date:  2005-02       Impact factor: 10.864

4.  Constitutive beta cell expression of IL-12 does not perturb self-tolerance but intensifies established autoimmune diabetes.

Authors:  A Holz; K Brett; M B Oldstone
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

5.  Innate inflammation drives NK cell activation to impair Treg activity.

Authors:  Joseph W Dean; Leeana D Peters; Christopher A Fuhrman; Howard R Seay; Amanda L Posgai; Scott E Stimpson; Maigan A Brusko; Daniel J Perry; Wen-I Yeh; Brittney N Newby; Michael J Haller; Andrew B Muir; Mark A Atkinson; Clayton E Mathews; Todd M Brusko
Journal:  J Autoimmun       Date:  2020-02-06       Impact factor: 7.094

6.  Interleukin-12 induces salivary gland dysfunction in transgenic mice, providing a new model of Sjögren's syndrome.

Authors:  Jelle L Vosters; Melissa A Landek-Salgado; Hongen Yin; William D Swaim; Hiroaki Kimura; Paul P Tak; Patrizio Caturegli; John A Chiorini
Journal:  Arthritis Rheum       Date:  2009-12

Review 7.  CNS infiltration of peripheral immune cells: D-Day for neurodegenerative disease?

Authors:  Kavon Rezai-Zadeh; David Gate; Terrence Town
Journal:  J Neuroimmune Pharmacol       Date:  2009-08-11       Impact factor: 4.147

8.  Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12.

Authors:  Burkhard Becher; Brigit G Durell; Randolph J Noelle
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808

9.  Characterization of effector T cells in dry eye disease.

Authors:  Jaafar El Annan; Sunil K Chauhan; Tatiana Ecoiffier; Qiang Zhang; Daniel R Saban; Reza Dana
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-04-01       Impact factor: 4.799

10.  Azithromycin suppresses interleukin-12p40 expression in lipopolysaccharide and interferon-gamma stimulated macrophages.

Authors:  Keiko Yamauchi; Yoko Shibata; Tomomi Kimura; Shuichi Abe; Sumito Inoue; Daisuke Osaka; Michiko Sato; Akira Igarashi; Isao Kubota
Journal:  Int J Biol Sci       Date:  2009-10-23       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.